Literature DB >> 6470707

Identification of bradykinin in mammalian brain.

D C Perry, S H Snyder.   

Abstract

Bradykinin-like activity was purified from acetic acid extracts of saline-perfused rat brains by gel filtration chromatography and two reverse-phase HPLC systems capable of resolving bradykinin from lysyl-bradykinin and other bradykinin analogs and fragments. Addition of [3H]bradykinin to extracts permitted calculation of recoveries and monitoring of chromatographic fractions. Fractions were examined by radioimmunoassay using a potent and highly specific antiserum raised against bradykinin-human albumin conjugates in rabbits. Bradykinin receptor-active material was also measured by radioreceptor assay using guinea pig ileum, as well as by a bioassay with the estrous rat uterus. Active material chromatographed as authentic bradykinin in all systems. Levels of 0.6 pmol/g whole rat brain were detected, with eight times higher levels in the hypothalamus. Activity increased up to 10-fold following treatment with trypsin; treatment with alpha-chymotrypsin or angiotensin-converting enzyme substantially reduced activity. Similar levels and distribution of bradykinin-like activity were also detected in guinea pig brain extracts. These data substantiate the existence of authentic bradykinin in mammalian brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470707     DOI: 10.1111/j.1471-4159.1984.tb12846.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Bradykinin-activated transmembrane signals are coupled via No or Ni to production of inositol 1,4,5-trisphosphate, a second messenger in NG108-15 neuroblastoma-glioma hybrid cells.

Authors:  H Higashida; R A Streaty; W Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Inactivation of kallikrein and kininases and stabilization of whole rat brain kinin levels following focused microwave irradiation.

Authors:  K Elrod; H Okamoto; L M Greenbaum; J J Buccafusco
Journal:  Neurochem Res       Date:  1986-10       Impact factor: 3.996

3.  Neurotransmitter release from bradykinin-stimulated PC12 cells. Stimulation of cytosolic calcium and neurotransmitter release.

Authors:  K C Appell; D S Barefoot
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Central adrenergic mediation of the cardiovascular effect of intraventricular bradykinin.

Authors:  F M Corrêa; J Ueta; I R Pelá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

5.  Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.

Authors:  E A DelBel; A P Padovan; G J Padovan; O Z Sellinger; A R Martins
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

6.  The effects of endothelium-dependent vasodilators on cardiac output and their distribution in the anaesthetized rat: a comparison with sodium nitroprusside.

Authors:  G R Thomas; C Thiemermann; C Walder; J R Vane
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

7.  The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice.

Authors:  Raimund Trabold; Christian Erös; Klaus Zweckberger; Jane Relton; Heike Beck; Juerg Nussberger; Werner Müller-Esterl; Michael Bader; Eric Whalley; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

8.  Bradykinin causes a transient rise of intracellular Ca2+-activity in cultured neural cells.

Authors:  G Reiser; B Hamprecht
Journal:  Pflugers Arch       Date:  1985-10       Impact factor: 3.657

9.  Cardiovascular effects of intrathecally administered bradykinin in the rat: characterization of receptors with antagonists.

Authors:  P Lopes; D Regoli; R Couture
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.

Authors:  N A Sharif; R L Whiting
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.